Orencia Injection, Solution
Product Images NDC 0003-2818

Product Visual Gallery

This gallery contains 51 technical images submitted to the FDA as part of the official labeling for Orencia (NDC 0003-2818). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by E.r. Squibb & Sons, L.l.c., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

A line graph titled 'Time Course of ACR 50 Response Inadequate Response to MTX (Study III)' showing percent responding on the y-axis and months on the x-axis. It compares response rates over 12 months between ORENCIA/MTX and Placebo/MTX groups, with ORENCIA/MTX showing a higher percentage of responders over time.*

FDA Label Image

Orencia-125mg-carton.jpg (Orencia 125mg Carton)

ORENCIA (abatacept) 125 mg/mL injection packaging label for a single-dose prefilled syringe with a BD UltraSafe Passive Needle Guard. The label indicates it is for subcutaneous use only and is manufactured by E.R. Squibb & Sons, L.L.C. The packaging includes dosing and usage instructions and safety warnings.*

FDA Label Image

Orencia-250mgvial (Orencia 250mgvial)

ORENCIA (abatacept) 250 mg/vial is a lyophilized powder for IV infusion shown in a folded carton label. The label indicates it is for injection, manufactured by E.R. Squibb & Sons, L.L.C. It includes instructions to see the full prescribing information and patient information guide inside the package.*

FDA Label Image

Orencia 4ct Clickjet Carton

Packaging label for ORENCIA ClickJect (abatacept) injection, 125 mg/mL, single-dose autoinjector for subcutaneous use. The label includes dosing instructions and safety warnings. The labeler is E.R. Squibb & Sons, L.L.C., and Bristol-Myers Squibb is referenced on the front panel. The packaging emphasizes refrigeration and single-use only.*

FDA Label Image

Orencia-50mg-carton.jpg (Orencia 50mg Carton)

ORENCIA (abatacept) injection 50 mg/0.4 mL single-dose prefilled syringe packaging label for subcutaneous use, indicated for juvenile idiopathic arthritis (JIA). The carton displays dosing and usage instructions and highlights the BD UltraSafe Passive Needle Guard. Labeler is E.R. Squibb & Sons, L.L.C.*

FDA Label Image

Orencia-87pt5mg-carton.jpg (Orencia 87pt5mg Carton)

Packaging label for ORENCIA (abatacept) 87.5 mg/0.7 mL single-dose prefilled syringe injection. It is indicated for subcutaneous use and designed for juvenile idiopathic arthritis treatment. The label includes the product name, dosage strength, form, and usage instructions. Manufactured by E.R. Squibb & Sons, L.L.C.*

FDA Label Image

Wait 30 Minutes (Orencia Ai 30minutes)

Illustration showing a circle with a vertical arrow inside and the text '30 Minutes' in the center, above which is the word 'WAIT' in red capital letters. The image indicates a 30-minute waiting time instruction.*

FDA Label Image

Autoinjector 90 Degree Angle (Orencia Ai 90degree)

An instructional diagram showing the proper technique for subcutaneous injection using an ORENCIA injection device. It depicts a hand holding the device at a 90-degree angle and another hand pinching the skin to prepare the injection site. The diagram highlights the injection window on the device and the skin pinch area on the arm.*

FDA Label Image

Autoinjector Injections Area Caregiver (Orencia Ai Arm)

An instructional diagram showing the recommended injection site for ORENCIA subcutaneous injection. It indicates the outer area of the upper arms as the preferred injection location, with a note specifying 'Caregiver ONLY.' The illustration depicts a torso focusing on the shoulder and upper arm areas.*

FDA Label Image

Autoinjector (Orencia Ai Autoinjector1)

An illustration of a drug delivery device resembling a prefilled autoinjector pen. The pen is primarily light blue with a white and yellowish base and features a blue push button on the top end. It is designed for subcutaneous injection, likely representing the ORENCIA injection device.*

FDA Label Image

Adhesive Bandage (Orencia Ai Bandage1)

An illustration of a beige adhesive bandage with a rectangular central pad and perforations covering its surface, typically used for minor wound care.*

FDA Label Image

Adhesive Bandage (Orencia Ai Bandage2)

An illustration showing an adhesive bandage with a label pointing to it. The diagram highlights the adhesive bandage component, typically used for covering injection sites or minor wounds.*

FDA Label Image

Autoinjector Check Device (Orencia Ai Checkdevice)

Illustration showing a hand holding a prefilled ORENCIA injection pen. The pen is labeled with the liquid medication inside and an indicated expiration date, demonstrating how to hold and examine the subcutaneous injection device before use.*

FDA Label Image

Cotton Ball (Orencia Ai Cotton1)

FDA Label Image

Cotton Ball (Orencia Ai Cottonball2)

Illustration showing a cotton ball or gauze with an adjacent label indicating the item. The image is a simple line drawing focusing on the appearance of the cotton ball or gauze.*

FDA Label Image

Autoinjector (Orencia Ai Cover)

ORENCIA 87.5 mg/0.7 mL subcutaneous injection pen device. The image shows a prefilled autoinjector pen with a light blue body and a white upper section containing a gray button. The label is partially visible near the blue end cap. This is a single-dose injection device labeled by E.R. Squibb & Sons, L.L.C.*

FDA Label Image

Autoinjector Into Sharps Container (Orencia Ai Injector Sharps)

An instructional illustration showing a prefilled injection pen with an arrow indicating disposal into a labeled sharps disposal container. This image demonstrates safe disposal of the used injection device.*

FDA Label Image

Autoinjector Press And Hold (Orencia Ai Presshold15sec)

An instructional illustration showing a hand holding a prefilled syringe positioned above the skin with an arrow pointing downward. Text indicates to press and hold the syringe for 15 seconds during injection, demonstrating the administration technique for a subcutaneous injection.*

FDA Label Image

Autoinjector Push Down (Orencia Ai Pushdown)

An instructional illustration showing a hand holding an injectable pen device. The pen is positioned above the skin on the forearm, with an arrow pointing downward labeled 'PUSH DOWN on skin,' indicating how to administer the subcutaneous injection by pressing the pen against the skin.*

FDA Label Image

Autoinjector Removal Of Needle Cover (Orencia Ai Remove Cover)

An instructional illustration showing hands holding a prefilled injection device and removing the needle cover prior to administration. Two red arrows indicate the direction to pull the needle cover away from the injection pen. The diagram is designed to guide proper preparation for subcutaneous injection.*

FDA Label Image

Sharps Disposal Container (Orencia Ai Sharps)

The image shows a red sharps disposal container with a beige lid. No text or product labeling is visible. This container is typically used for safe disposal of needles and other medical sharps.*

FDA Label Image

Alcohol Swab (Orencia Ai Swab)

An illustration shows a folded square gauze pad, which may be used in medical or injection site care. The gauze has a grid-like texture and appears to be a single layer.*

FDA Label Image

Autoinjector Injections Areas Torso (Orencia Ai Torso)

An instructional diagram showing recommended injection areas for ORENCIA (abatacept) subcutaneous injection. The diagram highlights the abdomen (avoiding 2 inches around the navel) and the front of the thighs as appropriate sites for self-injection or injection by a caregiver.*

FDA Label Image

Autoinjector Wait For Indicator (Orencia Ai Wait)

An instructional illustration showing a close-up of a subcutaneous injection device with a blue indicator and the instruction to wait until the blue indicator stops moving before proceeding. This likely relates to proper use of the ORENCIA injection device.*

FDA Label Image

Autoinjector After Use (Orencia Autoinj Afteruse)

An illustration showing an ORENCIA autoinjector pen for subcutaneous injection. The image highlights features including a blue indicator and a transparent tip on the injection device, used for administering abatacept injection.*

FDA Label Image

Autoinjector Before Use (Orencia Autoinj Beforeuse)

Illustration of a subcutaneous injection pen for ORENCIA (abatacept) showing labeled parts including the needle cover with an orange cap, a viewing window, a blue grip section, the expiration date area, and a blue activation button.*

FDA Label Image

Orencia Figure 2 % Of Patients Achieving Acr20 (Orencia Fig2)

A line graph comparing ACR 20 response rates over time between ORENCIA 125 mg and placebo groups. The x-axis shows days ranging from 15 to 169, and the y-axis shows response rates from 0 to 50. The graph depicts higher response rates for ORENCIA throughout the study period.*

FDA Label Image

Three Dose Versions (Orencia Ssi 3 Dose Vers)

An instructional illustration showing three syringes for ORENCIA (abatacept) subcutaneous injection. Each syringe dose is identified by volume, strength, and plunger color: 50 mg/0.4 mL with a white plunger, 87.5 mg/0.7 mL with a light blue plunger, and 125 mg/mL with an orange plunger.*

FDA Label Image

Syringe After Use (Orencia Ssi After Use)

An instructional illustration showing a prefilled syringe with a needle guard extended over the needle and a flange extender attached. The syringe barrel is labeled with an expiration date. This diagram highlights the syringe safety and handling features for injection administration.*

FDA Label Image

Complete All Steps (Orencia Ssi Allsteps)

An instructional illustration showing three sequential steps for using a subcutaneous injection device. The images depict pressing the plunger to inject, removing the needle guard after injection, and a final step confirming needle removal with a clicking sound. The injection device appears consistent with a prefilled syringe format.*

FDA Label Image

Adhesive Bandage (Orencia Ssi Bandage1)

FDA Label Image

Syringe Before Use (Orencia Ssi Before Use)

Illustration of a subcutaneous injection syringe showing labeled parts including the needle cover, viewing window, expiration date, flange extender, and plunger. The diagram is designed to aid in understanding syringe components relevant to injectable drug administration.*

FDA Label Image

Injection Site For Caregiver Only (Orencia Ssi Caregiveronly)

An instructional diagram showing the recommended injection site area for ORENCIA (abatacept) subcutaneous injection. The highlighted zones are the outer areas of the upper arms, specifically marked for caregiver use only during administration.*

FDA Label Image

Cotton Or Gauze And Bandage (Orencia Ssi Cotton And Bandage)

An instructional illustration showing a cotton ball or gauze pad and an adhesive bandage, labeled accordingly. The image appears to demonstrate items used for wound care or post-injection treatment, but no product branding or medication details are visible.*

FDA Label Image

Cottonball (Orencia Ssi Cotton1)

ORENCIA 125 mg/mL injection, solution in a single-dose vial with a white label displaying the product name, dosage strength, and manufacturer, E.R. Squibb & Sons, L.L.C. The vial contains a clear liquid for subcutaneous use.*

FDA Label Image

125 mg/ml Prefilled Syringe (Orencia Ssi Cover)

Illustration of a prefilled syringe of ORENCIA (abatacept) injection, solution for subcutaneous use. The syringe features a protective cap, a safety shield, and an orange plunger, designed to deliver a sterile dosage.*

FDA Label Image

Do Not (Orencia Ssi Do Not 02)

FDA Label Image

Do Not (Orencia Ssi Do Not)

FDA Label Image

Examine The Liquid (Orencia Ssi Examine Liquid)

An illustration diagram showing the tip of a syringe with a liquid inside, an air bubble, and a viewing window labeled to identify these components. The image depicts the position of liquid and air within the syringe tip.*

FDA Label Image

Examine The Syringe (Orencia Ssi Examine Syringe)

An instructional illustration showing a hand holding a syringe labeled ORENCIA (abatacept) injection. The diagram highlights key parts of the syringe including the expiration date, body, and needle cover, demonstrating how to correctly hold and identify components for subcutaneous injection.*

FDA Label Image

Insert The Needle (Orencia Ssi Insert)

An instructional illustration demonstrating the proper technique for subcutaneous injection using a syringe. The image shows a hand holding a syringe at a 45-degree angle, inserting the needle into the skin of a forearm or hand.*

FDA Label Image

Inspect Your Dose (Orencia Ssi Inspect Dose)

An instructional illustration showing three prefilled syringes of ORENCIA (abatacept) injection, solution for subcutaneous use. The syringes are labeled with different strengths and volumes: 50 mg/0.4 mL with a white plunger and 0.4 mL fill line, 87.5 mg/0.7 mL with a light blue plunger and 0.7 mL fill line, and 125 mg/mL with an orange plunger and 1 mL fill line. Each syringe is shown with its respective fill line and plunger color.*

FDA Label Image

Remove Needle Cover (Orencia Ssi Needlecover)

An instructional illustration showing a hand removing the needle cover from a syringe or injection device labeled ORENCIA. The image highlights the needle cover being pulled off, indicating preparation for subcutaneous injection.*

FDA Label Image

Pinch The Skin (Orencia Ssi Pinch)

An instructional illustration showing a person pinching the skin of their thigh or abdomen while holding a syringe for subcutaneous injection. The image indicates the proper technique to pinch the skin before injecting.*

FDA Label Image

Injection Sites For Self And Caregiver (Orencia Ssi Self Caregvr)

An instructional diagram showing recommended injection areas for ORENCIA (abatacept) subcutaneous injection. The diagram highlights the abdomen area, advising to avoid a 2-inch area around the navel, and the front of the thighs as proper sites for self-injection or caregiver administration.*

FDA Label Image

Sharps Container (Orencia Ssi Sharps)

ORENCIA injection solution in a subcutaneous dosage form is presented in a red sharps disposal container with a beige lid. The image shows the container used for safe disposal of used injection needles but does not display dosage strength or labeler information.*

FDA Label Image

Dispose Into Sharps Container (Orencia Ssi Sharpscont)

Illustration showing the disposal process of a prefilled injection syringe into a red sharps disposal container, indicating safe disposal of used injection equipment.*

FDA Label Image

Prefilled Syringe (Orencia Ssi Supplies)

ORENCIA 125 mg/mL injection solution in a prefilled syringe for subcutaneous use with abatacept as the active ingredient. The image shows a syringe with a label displaying "125 mg" indicating the strength. The product is labeled by E.R. Squibb & Sons, L.L.C.*

FDA Label Image

Alcohol Swab (Orencia Ssi Swab)

FDA Label Image

Wait 30 Minutes (Orencia Ssi Wait30)

An instructional graphic showing a circular timer with an arrow indicating a 30-minute wait time, accompanied by the word 'WAIT' in red above the circle. This appears to emphasize waiting for 30 minutes.*

FDA Label Image

Wash Hands (Orencia Ssi Washhands)

An instructional illustration showing two hands being washed under running water with soap lather, emphasizing hand hygiene.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.